Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells
about
Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulationThe effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii.Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep.Could the airway epithelium play an important role in mucosal immunoglobulin A production?Breakage of B cell tolerance and autoantibody production in anti-erythrocyte transgenic mice.Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.Recombinant Dirofilaria immitis polyprotein that stimulates murine B cells to produce nonspecific polyclonal immunoglobulin E antibodyCutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis.Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destructionRecent progress in the understanding of B-cell functions in autoimmunity.Polymer IgM assembly and secretion in lymphoid and nonlymphoid cell lines: evidence that J chain is required for pentamer IgM synthesis.Evidence for a modulatory effect of IL-10 on both Th1 and Th2 cytokine production: the role of the environment.Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells.Interleukin-12 and -10 and gamma interferon regulate polyclonal and ligand-specific expansion of murine B-1 cells.The Effects of Post-Mating Administration of Anti-IL-10 and Anti-TGFß on Conception Rates in MiceHuman B-1 cells take the stage.Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathwayIdentification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy.New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice.Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression.Regulation of contact hypersensitivity by interleukin 10.Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes.Btk dosage determines sensitivity to B cell antigen receptor cross-linkingIL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.Interleukin-10 prevents epithelial cell apoptosis by regulating IFNγ and TNFα expression in rhesus macaque colon explants.Adult BM generates CD5+ B1 cells containing abundant N-region additions.Cell type-specific regulation of IL-10 expression in inflammation and disease.The immune system as a self-centered network of lymphocytes.Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition.Interleukin-10 and cancer.The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages.Cytokines and their role as growth factors and in regulation of immune responses.Bar Mitzvah for B-1 cells: how will they grow up?
P2860
Q24594899-6C8A0768-1A18-47DE-A8A1-1A3AE830D162Q28238494-144D9311-BDFB-4060-85BB-910B2BF07087Q30786199-0F17D3BF-8E09-45D7-BA49-4A66C00EBA29Q33609623-7E22791E-0F20-48CE-BB83-1A67867BC72DQ33782898-2146BE8A-A726-4961-BFED-5C3E96A1C500Q33792418-2FD9BCBD-6FA1-4353-AF6D-CE2D74CBFE25Q33805873-4764CBDA-13C3-4F76-A2BB-EEFE261D1F0BQ33901807-27EE5145-470F-4E56-B74F-C14CFDCD7955Q34118973-F03C2EA4-1381-49A7-B57B-4CE07A21EF09Q34130293-C04C04E6-9B4E-4329-869B-449B9BCF603BQ34134530-FEDBE9EB-FF0F-4E04-AEB3-92EEA5CD1614Q34299834-73EB282F-A983-4ACC-81FD-FE80319BDF33Q34513001-417E1E98-DAC2-4821-8303-B8F7732FF0FEQ34762084-3808A4F5-E754-4536-AF16-893314D06078Q35115832-B804380E-F718-41CA-837F-DEAF4C725EA1Q35528365-52FCBE65-CEF2-418C-8767-1B32DF257B2BQ35539023-07C30341-C54E-4A8C-9246-3613E8982092Q35600416-E8878C50-CC67-4C49-B874-CE5999742B7CQ35609739-D6F5D7A5-9A3C-4AB1-81DF-C3038479AB27Q35736080-18F4D898-A09C-4D18-BD60-B32D2F3B076DQ35871318-887EC1A0-A910-458B-9382-1A63372FDC30Q36184396-6DFA076E-54ED-40DC-AE82-9BDAE3B292F5Q36260899-7C54309F-BF29-4641-9E3E-8FF067DF320CQ36361165-E5A934A7-7962-4DAB-8802-0D94CC7CB763Q36363097-D60A1BCD-615B-4056-A1B7-942C083CE4F3Q36363160-A9E01A16-7648-41AD-A1EB-DC4E9EF160E5Q36364479-743F6007-F76E-4F97-AA2F-D4A00A716832Q36367253-75CCB077-7524-4C0F-98DB-88881C2AE001Q36720312-A23C4DBE-1BCF-450A-8BD0-A30AC85FB765Q36849075-75D8FEA0-EC7E-4123-91BF-5F16F40CE0ADQ37164783-9BD1F8AC-1E0E-45B6-AC0A-01EBCB6A02E5Q37473951-30781FF8-D971-4F3A-A25B-FDB33C693D1AQ37678256-B57FBB0D-BAB1-4037-B37D-6B1DBBE2845AQ38532648-2137A162-64FA-492A-9F86-9A2FECBC33D4Q39860514-52BDBD42-954D-4191-9AA0-263C6FCE4546Q40387286-C3001468-BAD0-4EDA-B511-43929751E86BQ40772002-1EDA7882-A883-4ECC-8FDF-8B73AE2D642DQ40816643-119879A2-F3EE-4ED9-BC79-3CE2432DE71CQ40841539-045BB6A9-192B-4541-89FB-1F9873285A08Q41416484-4E99EFD1-5798-42DB-96BF-4BDAD63A6DDC
P2860
Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Continuous anti-interleukin 10 ...... s but not conventional B cells
@ast
Continuous anti-interleukin 10 ...... s but not conventional B cells
@en
type
label
Continuous anti-interleukin 10 ...... s but not conventional B cells
@ast
Continuous anti-interleukin 10 ...... s but not conventional B cells
@en
prefLabel
Continuous anti-interleukin 10 ...... s but not conventional B cells
@ast
Continuous anti-interleukin 10 ...... s but not conventional B cells
@en
P2093
P2860
P356
P1476
Continuous anti-interleukin 10 ...... s but not conventional B cells
@en
P2093
P2860
P304
P356
10.1084/JEM.175.5.1213
P407
P577
1992-05-01T00:00:00Z